213 related articles for article (PubMed ID: 15459152)
1. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension.
Minder S; Fischler M; Muellhaupt B; Zalunardo MP; Jenni R; Clavien PA; Speich R
Eur Respir J; 2004 Oct; 24(4):703-7. PubMed ID: 15459152
[TBL] [Abstract][Full Text] [Related]
2. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
[TBL] [Abstract][Full Text] [Related]
3. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
[TBL] [Abstract][Full Text] [Related]
4. Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis.
Molnar C; Alber H; Colleselli D; Vogel W; Kähler CM
Wien Klin Wochenschr; 2004 Sep; 116(17-18):627-30. PubMed ID: 15515882
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
Halank M; Kolditz M; Miehlke S; Schiemanck S; Schmeisser A; Hoeffken G
Wien Med Wochenschr; 2005 Aug; 155(15-16):376-80. PubMed ID: 16160926
[TBL] [Abstract][Full Text] [Related]
6. [Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis].
Dietrich CG; Gartung C; Siewert E; Lammert F; Matern S; Geier A
Z Gastroenterol; 2006 Jan; 44(1):33-7. PubMed ID: 16397837
[TBL] [Abstract][Full Text] [Related]
7. [Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis].
Halank M; Ewert R; Opitz C; Seyfarth HJ; Höffken G
Z Gastroenterol; 2006 Apr; 44(4):346-7; author reply 348. PubMed ID: 16708443
[No Abstract] [Full Text] [Related]
8. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation.
Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM
Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol.
Tan HP; Markowitz JS; Montgomery RA; Merritt WT; Klein AS; Thuluvath PJ; Poordad FF; Maley WR; Winters B; Akinci SB; Gaine SP
Liver Transpl; 2001 Aug; 7(8):745-9. PubMed ID: 11510023
[TBL] [Abstract][Full Text] [Related]
10. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
[TBL] [Abstract][Full Text] [Related]
11. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension.
Kuo PC; Johnson LB; Plotkin JS; Howell CD; Bartlett ST; Rubin LJ
Transplantation; 1997 Feb; 63(4):604-6. PubMed ID: 9047158
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.
Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA
Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330
[TBL] [Abstract][Full Text] [Related]
13. Novel use of sildenafil in the treatment of portopulmonary hypertension.
Chua R; Keogh A; Miyashita M
J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
[TBL] [Abstract][Full Text] [Related]
14. Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C.
Grander W; Eller P; Fuschelberger R; Tilg H
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():67-70. PubMed ID: 16919014
[TBL] [Abstract][Full Text] [Related]
15. Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension.
Halank M; Marx C; Miehlke S; Hoeffken G
J Gastroenterol; 2004 Dec; 39(12):1222-3. PubMed ID: 15622492
[No Abstract] [Full Text] [Related]
16. Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation.
Scouras NE; Matsusaki T; Boucek CD; Wells C; Cooper EA; Planinsic RM; Sullivan EA; Bermudez CA; Toyoda Y; Sakai T
Liver Transpl; 2011 Feb; 17(2):137-43. PubMed ID: 21280186
[TBL] [Abstract][Full Text] [Related]
17. Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension.
Uchiyama H; Soejima Y; Taketomi A; Yoshizumi T; Harada N; Ijichi H; Yonemura Y; Maehara Y
Liver Transpl; 2006 Mar; 12(3):481-4. PubMed ID: 16498645
[TBL] [Abstract][Full Text] [Related]
18. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
Sağ S; Yeşilbursa D; Güllülü S
Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
Fix OK; Bass NM; De Marco T; Merriman RB
Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
[TBL] [Abstract][Full Text] [Related]
20. Successful outcomes following living donor liver transplantation for portopulmonary hypertension.
Bandara M; Gordon FD; Sarwar A; Knauft ME; Pomfret EA; Freeman RB; Wirth JA
Liver Transpl; 2010 Aug; 16(8):983-9. PubMed ID: 20677289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]